Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2026-02-27 @ 1:08 AM
Study NCT ID:
NCT02237261
Status:
COMPLETED
Last Update Posted:
2020-10-19
First Post:
2014-06-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
Sponsor:
University Hospital Heidelberg
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BPV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None